Related Experiment Videos

Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma

H Nakagomi1, P Pisa, E K Pisa

  • 1MTC, Karolinska Institute, Stockholm, Sweden.

Insights

Tumor-infiltrating lymphocytes (TIL) in kidney cancer show altered cytokine gene expression. Interleukin-10 (IL-10) mRNA was found only in tumors, suggesting a role in suppressing anti-tumor immunity.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Freshly isolated tumor-infiltrating lymphocytes (TIL) often exhibit functional deficiencies.
  • Cytokine production is a critical parameter of immune response efficacy.

Purpose of the Study:

  • To investigate the constitutive expression of cytokine genes in freshly isolated renal cancer tissue.
  • To compare cytokine mRNA expression between renal tumors, cancer cell lines, peripheral blood mononuclear cells (PBMC), and non-tumor kidney tissue.

Main Methods:

  • Utilized a PCR-assisted mRNA amplification assay to assess cytokine gene expression.
  • Analyzed mRNA for 10 different cytokines in various kidney tissue and cell samples.

Main Results:

  • Interleukin-10 (IL-10) mRNA was exclusively detected in tumor samples, not in cell lines, PBMC, or normal kidney tissue.
  • Granulocyte-colony stimulating factor (G-CSF) mRNA was found in one-third of tumors but not normal kidney tissue.
  • Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-alpha), and Interferon-gamma (IFN-gamma) mRNA were expressed across tumors, PBMC, and normal tissue.

Conclusions:

  • The exclusive presence of IL-10 mRNA in renal tumors suggests its potential role in suppressing local anti-tumor immune responses.
  • Findings indicate that IL-10 may impair antigen presentation, impacting the effectiveness of the local immune surveillance against cancer.

Related Concept Videos